Literature DB >> 16430400

Use of statistics to assess the global burden of breast cancer.

D Maxwell Parkin1, Leticia M G Fernández.   

Abstract

A variety of statistics are used to quantify the burden (occurrence and outcome) of cancer generally and of breast cancer specifically. When undertaking any cancer control program, understanding these statistics, their source, and their quality is important for assessing the current situation, allocating resources to different control strategies, and evaluating progress. Two core statistics are the cancer incidence rate and the cancer mortality rate, which provide estimates of the average risk of acquiring and of dying from the disease, respectively. About 16% of the world's population is covered by registration systems that produce cancer incidence statistics, while mortality data are available for about 29%. Breast cancer incidence and mortality vary considerably by world region. In general, the incidence is high (greater than 80 per 100,000) in developed regions of the world and low (less than 30 per 100,000), though increasing, in developing regions; the range of mortality rates is much less (approximately 6-23 per 100,000) because of the more favorable survival of breast cancer in (high-incidence) developed regions. The incidence of breast cancer is increasing almost everywhere. This unfavorable trend is due in part to increases in risk factors (decreased childbearing and breast-feeding, increased exogenous hormone exposure, and detrimental dietary and lifestyle changes, including obesity and less physical activity). On the other hand, mortality is now decreasing in many high-risk countries due to a combination of intensified early detection efforts and the introduction of mammographic screening, resulting in the diagnosis of more small, early stage tumors, and advances in treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16430400     DOI: 10.1111/j.1075-122X.2006.00205.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  113 in total

1.  Urban-rural differences in breast cancer incidence in Egypt (1999-2006).

Authors:  Subhojit Dey; Amr S Soliman; Ahmad Hablas; Ibrahim A Seifeldein; Kadry Ismail; Mohamed Ramadan; Hesham El-Hamzawy; Mark L Wilson; Mousumi Banerjee; Paolo Boffetta; Joe Harford; Sofia D Merajver
Journal:  Breast       Date:  2010-05-08       Impact factor: 4.380

2.  Breast Cancer in Low and Middle Income Countries: How Can Guidelines Best Be Disseminated and Implemented?

Authors:  Benjamin O Anderson; Vivien D Tsu
Journal:  Breast Care (Basel)       Date:  2008-02-22       Impact factor: 2.860

3.  Fungating Breast Cancer: Experience in Low and Middle Income Country.

Authors:  Raouef Ahmed Bichoo; Sanjay Kumar Yadav; Anjali Mishra; Punita Lal; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Saroj K Mishra
Journal:  Indian J Surg Oncol       Date:  2020-02-19

Review 4.  Updated evidence in support of diet and exercise interventions in cancer survivors.

Authors:  Dorothy W Pekmezi; Wendy Demark-Wahnefried
Journal:  Acta Oncol       Date:  2010-11-24       Impact factor: 4.089

5.  Assessing patterns of practice of sentinel lymph node biopsy for breast cancer in Latin America.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

6.  The effect of regular exercise on quality of life among breast cancer survivors.

Authors:  Xiaoli Chen; Ying Zheng; Wei Zheng; Kai Gu; Zhi Chen; Wei Lu; Xiao Ou Shu
Journal:  Am J Epidemiol       Date:  2009-08-20       Impact factor: 4.897

Review 7.  Autophagy and endocrine resistance in breast cancer.

Authors:  Katherine L Cook; Ayesha N Shajahan; Robert Clarke
Journal:  Expert Rev Anticancer Ther       Date:  2011-08       Impact factor: 4.512

8.  A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.

Authors:  Thomas E Rohan; Abdissa Negassa; Rowan T Chlebowski; Clementina D Ceria-Ulep; Barbara B Cochrane; Dorothy S Lane; Mindy Ginsberg; Sylvia Wassertheil-Smoller; David L Page
Journal:  Breast Cancer Res Treat       Date:  2008-10-14       Impact factor: 4.872

9.  Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.

Authors:  Elizabeth W LaPensee; Sandy J Schwemberger; Christopher R LaPensee; El Mustapha Bahassi; Scott E Afton; Nira Ben-Jonathan
Journal:  Carcinogenesis       Date:  2009-05-14       Impact factor: 4.944

Review 10.  Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative.

Authors:  Benjamin O Anderson; Raimund Jakesz
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.